Validation and reliability study of the Turkish version of the Neuroquality of Life (Neuro-QoL)-Stigma Scale for neurological disorders

Basit Öğe Kaydı
dc.authorid0000-0002-2887-9235en_US
dc.authorid0000-0003-3868-3137en_US
dc.authorid0000-0003-2016-9965en_US
dc.authorid0000-0003-1895-7217en_US
dc.authorid0000-0001-5953-4240en_US
dc.contributor.authorKarşıdağ, Sibel
dc.contributor.authorÇınar, Nilgün
dc.contributor.authorŞahin, Şevki
dc.contributor.authorKotevoğlu, Nurdan
dc.contributor.authorAteş, Miruna Florentina
dc.date.accessioned2024-07-12T21:11:53Z
dc.date.available2024-07-12T21:11:53Z
dc.date.issued2019en_US
dc.departmentFakülteler, Tıp Fakültesien_US
dc.description.abstractBackground/aim: Stigma can be defined as a negative perception of chronically ill patients by their relatives or by society, or a similar self-perception by the patients themselves. We aimed to validate the Turkish version of the Neuroquality of Life (Neuro-QoL)-Stigma Scale for neurologic diseases. Materials and methods: Forms were filled out by a total of 152 randomized patients under regular follow-up in the outpatient clinic (29 polyneuropathy, 25 epilepsy, 23 stroke, 24 tension-type headache, 28 multiple sclerosis, 27 Parkinson disease). The forms consisted of the Beck Depression Inventory (BDI), Beck Anxiety Inventory (BAI), WHOQOL-BREF quality of life scale, the Multidimensional Scale of Perceived Social Support (MSPSS), the General Self-Efficacy (GSE) scale, and the Neuro-QoL-Stigma scale. Results: The internal consistency of the Neuro-QoL-Stigma scale showed Cronbach’s ? coefficients of 0.95 for all groups. The mean scores of the stigma scales were 33.42 ± 13.91 (min–max: 24–87). There were strong negative correlations between high stigma scores and GSE-T, MSPSS-T, and WHOQOL-BREF, and a positive correlation with the BDI and BAI. Conclusion: The Turkish version of Neuro-QoL-Stigma has satisfactory content validity and high internal consistency. Neuro-QoL-Stigma is suitable for understanding stigmatization in different neurological disorders in the Turkish population. The scale is available for use at http://www.healthmeasures.net/explore-measurement-systems/neuro-qol.en_US
dc.identifier.citationKarşıdağ, S., Çınar, N., Şahin, Ş., Kotevoğlu, N. ve Ateş, M.F. (2019). Validation and reliability study of the Turkish version of the Neuroquality of Life (Neuro-QoL)-Stigma Scale for neurological disorders. 49(3), s. 789-794.en_US
dc.identifier.doi10.3906/sag-1811-50
dc.identifier.endpage794en_US
dc.identifier.issn1303-6165
dc.identifier.issue3en_US
dc.identifier.pmid31023004en_US
dc.identifier.scopus2-s2.0-85070221928en_US
dc.identifier.scopusqualityQ3en_US
dc.identifier.startpage789en_US
dc.identifier.trdizinid336177en_US
dc.identifier.urihttps://pubmed.ncbi.nlm.nih.gov/31023004/
dc.identifier.urihttps://doi.prg/10.3906/sag-1811-50
dc.identifier.urihttps://hdl.handle.net/20.500.12415/4427
dc.identifier.volume49en_US
dc.identifier.wosWOS:000471902200013en_US
dc.identifier.wosqualityQ4en_US
dc.indekslendigikaynakWeb of Science
dc.indekslendigikaynakScopus
dc.indekslendigikaynakTR-Dizin
dc.indekslendigikaynakPubMed
dc.institutionauthorKarşıdağ, Sibel
dc.institutionauthorÇınar, Nilgün
dc.institutionauthorŞahin, Şevki
dc.institutionauthorKotevoğlu, Nurdan
dc.institutionauthorAteş, Miruna Florentina
dc.language.isoenen_US
dc.publisherTÜBİTAKen_US
dc.relation.ispartofTurkish Journal of Medical Sciencesen_US
dc.relation.publicationcategoryUluslararası Hakemli Dergide Makale - Kurum Öğretim Elemanıen_US
dc.rightsinfo:eu-repo/semantics/openAccessen_US
dc.snmzKY03734
dc.subjectStigmaen_US
dc.subjectneurologyen_US
dc.subjectNeuro-QoLen_US
dc.subjectvalidationen_US
dc.titleValidation and reliability study of the Turkish version of the Neuroquality of Life (Neuro-QoL)-Stigma Scale for neurological disordersen_US
dc.typeArticle
dspace.entity.typePublication

Dosyalar

Koleksiyon

Tıp Fakültesi Koleksiyonu
PubMed İndeksli Yayınlar Koleksiyonu
Scopus İndeksli Yayınlar Koleksiyonu
TR-Dizin İndeksli Yayınlar Koleksiyonu
WoS İndeksli Yayınlar Koleksiyonu